Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer.
暂无分享，去创建一个
Qiang Yu | B. Teh | T. Kang | Jieping Chen | Jing Tan | J. Bei | Peng Deng | Xiaosai Yao | Jianfeng Chen | Jihong Liu | P. Guan | J. Chan | J. Koh | J. H. Hong | Jinghong Chen | Yichen Sun | Y. Xiong | Hui Liu | Rui Chen | Weiting Liang | Huaiwu Lu | Rong Xiao | Jiaxin Yin | Zhaoliang Yu | Shini Liu | Qiong Zou | Xiaowei Lai | Baohua Wang | Tiebang Kang | Tiebang Kang | J. Hong